LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹166 Cr | ₹162 Cr | ₹136 Cr | ₹116 Cr | ₹113 Cr |
What is the latest Sundry Debtors ratio of LINCOLN PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹166 Cr |
| Mar2024 | ₹162 Cr |
| Mar2023 | ₹136 Cr |
| Mar2022 | ₹116 Cr |
| Mar2021 | ₹113 Cr |
How is Sundry Debtors of LINCOLN PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹166 Cr | 2.86 | |
| Mar2024 | ₹162 Cr | 18.66 | |
| Mar2023 | ₹136 Cr | 17.59 | |
| Mar2022 | ₹116 Cr | 2.29 | |
| Mar2021 | ₹113 Cr | - | |
Compare Sundry Debtors of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹973.2 Cr | 1.1% | -8.5% | -47.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,753.0 Cr | -0.2% | 1.1% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,205.0 Cr | 0.7% | -2.9% | 6.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,169.0 Cr | -0.9% | -1.6% | 13.6% | Stock Analytics | |
| CIPLA | ₹121,166.0 Cr | 0.7% | -2.4% | 4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,749.0 Cr | 2.2% | 2.8% | 2.8% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 1.1% |
-8.5% |
-47.5% |
| SENSEX | 0% |
0.1% |
3.9% |
You may also like the below Video Courses